English
简体中文
Total: £ 56.28
2026-02-06 | Pages: 121 | Tables: 126
The global Tramadol Hydrochloride Injection market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global econo...
2026-02-06 | Pages: 108 | Tables: 110
The global Kanamycin Sulfate Injection market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic lan...
2026-02-06 | Pages: 110 | Tables: 117
The global Estradiol Patches market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. Th...
2026-02-06 | Pages: 108 | Tables: 110
The global HRT Patches market was valued at US$ 157 million in 2025 and is anticipated to reach US$ 248 million by 2032, at a CAGR of 6.8% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landsca...
2026-02-06 | Pages: 90 | Tables: 95
The global Etofenamate Preparations market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Etofenamate is a nonsteroidal anti-inflammatory drug (NSAID) used for the treatment of joint...
2026-02-06 | Pages: 126 | Tables: 119
The global Psoriasis Biosimilar market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape....
2026-02-06 | Pages: 95 | Tables: 105
The global Budesonide and Formoterol Powder Inhalation market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the glo...
2026-02-06 | Pages: 97 | Tables: 97
The global Budesonide and Formoterol Inhalation market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global eco...
2026-02-06 | Pages: 95 | Tables: 107
The global Ubenimex Capsules market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. Th...
2026-02-06 | Pages: 127 | Tables: 140
The global Cefuroxime Axetil Drug market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Cefuroxime Axetil is a cephalosporin antibiotic. It is used to treat a wide variety of bacteri...
2026-02-06 | Pages: 114 | Tables: 113
The global Peptide-Radionuclide Conjugates (PRCs) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global e...
2026-02-06 | Pages: 135 | Tables: 139
The global Gout Medications market was valued at US$ 3874 million in 2025 and is anticipated to reach US$ 6391 million by 2032, at a CAGR of 7.5% from 2026 to 2032.Gout medications comprise agents for prevention and treatment of gout and hyperuricemi...
2026-02-06 | Pages: 145 | Tables: 140
The global Drugs Used for Treating Primary Aldosteronism market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the g...
2026-02-06 | Pages: 140 | Tables: 146
The global Steroidal MRAs market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This ...
2026-02-06 | Pages: 137 | Tables: 134
The global Platelet Rich Plasma (PRP) Preparation Kits market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the glo...
